Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.72
+0.12 (2.14%)
Nov 21, 2024, 1:59 PM EST - Market open
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
66
Market Cap
485.85M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Community Health Systems | 12.55B |
Pharming Group | 285.75M |
SI-BONE | 157.04M |
GRAIL | 117.67M |
Y-mAbs Therapeutics | 84.55M |
PureTech Health | 468.00K |
TERN News
- 2 days ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 2 days ago - Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewsWire
- 6 days ago - RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking. - Market Watch
- 6 weeks ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 2 months ago - Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst - Seeking Alpha
- 2 months ago - Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic - Seeking Alpha
- 2 months ago - Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Terns Announces Pricing of Upsized $150.15 Million Public Offering - GlobeNewsWire